Form 8-K - Current report:
SEC Accession No. 0001213900-25-000191
Filing Date
2025-01-02
Accepted
2025-01-02 11:11:40
Documents
14
Period of Report
2025-01-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0226314-8k_silopharma.htm   iXBRL 8-K 29360
2 JANUARY 2, 2025 LETTER TO SHAREHOLDERS ea022631401ex99-1_silopharma.htm EX-99.1 24552
  Complete submission text file 0001213900-25-000191.txt   234532

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE silo-20250102.xsd EX-101.SCH 3021
4 XBRL LABEL FILE silo-20250102_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE silo-20250102_pre.xml EX-101.PRE 22363
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0226314-8k_silopharma_htm.xml XML 3566
Mailing Address 677 N. WASHINGTON BLVD SARASOTA FL 34236
Business Address 677 N. WASHINGTON BLVD SARASOTA FL 34236 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

EIN.: 462137136 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41512 | Film No.: 25500842
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)